Fidia Raises Share Capital as GGHL Converts Seven POC Bonds

Fidia Spa ( (IT:FDA) ) just unveiled an update.

Fidia S.p.A. has announced the conversion of seven bonds from the third tranche of its convertible bond loan with warrants, subscribed by Global Growth Holding Limited, into 1,750,000 new shares at a unit price of €0.04. The new shares are admitted directly to trading on the regulated market under the existing prospectus, reinforcing the company’s equity base.

Following this operation, the share capital increase linked to the POC has reached €730,000 of a €750,000 subscribed nominal amount, with two bonds still to be converted. As a result, Fidia’s share capital rises by €70,000 to €10,577,761.90, and the total number of outstanding shares grows to 41,042,927, modestly diluting existing shareholders while supporting the company’s financing structure.

The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.11 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.

More about Fidia Spa

Fidia S.p.A., based in Turin and listed on Euronext Milan, is a global player in high-performance integrated milling systems, serving primarily the automotive mould and aerospace sectors. With more than 50 years of experience and around 135 employees, the group offers end-to-end solutions for the milling process, including numerical controls, high-speed milling systems and CAM software for complex shapes.

Average Trading Volume: 1,140,967

Technical Sentiment Signal: Strong Sell

Current Market Cap: €1.39M

For detailed information about FDA stock, go to TipRanks’ Stock Analysis page.